Inventor
SPEVAK WAYNE
US56 patents
⚠️ This page may combine multiple inventors who share the name “SPEVAK WAYNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PLEXXIKON INC
37 patentsUS9771363B2Sep 26, 2017
Heterocyclic compounds and uses thereof
PLEXXIKON INC34 citations98
US9469640B2Oct 18, 2016
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC44 citations98
US7863288B2Jan 4, 2011
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC187 citations98
US7846941B2Dec 7, 2010
Compounds modulating c-kit and c-fms activity and uses therefor
PLEXXIKON INC92 citations98
US7863289B2Jan 4, 2011
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC131 citations97
US10370374B2Aug 6, 2019
Heterocyclic compounds and uses thereof
PLEXXIKON INC17 citations94
US9975894B2May 22, 2018
Heterocyclic compounds and uses thereof
PLEXXIKON INC20 citations94
US9822109B2Nov 21, 2017
Heterocyclic compounds and uses thereof
PLEXXIKON INC23 citations94
US9814714B2Nov 14, 2017
Kinase modulation, and indications therefor
PLEXXIKON INC22 citations94
US9771369B2Sep 26, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC24 citations94
US9718847B2Aug 1, 2017
Heterocyclic compounds and uses thereof
PLEXXIKON INC33 citations94
US9682981B2Jun 20, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC25 citations94
US9676748B2Jun 13, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC23 citations94
US9617267B2Apr 11, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC38 citations94
US9440969B2Sep 13, 2016
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC40 citations94
US9096593B2Aug 4, 2015
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC34 citations94
US9994567B2Jun 12, 2018
Synthesis of heterocyclic compounds
PLEXXIKON INC14 citations93
US9873700B2Jan 23, 2018
Compounds for kinase modulation, and indications therefor
PLEXXIKON INC20 citations93
US9844539B2Dec 19, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC20 citations93
US9776998B2Oct 3, 2017
Synthesis of heterocyclic compounds
PLEXXIKON INC20 citations93
US9856259B2Jan 2, 2018
Heterocyclic compounds and uses thereof
PLEXXIKON INC20 citations86
US9938273B2Apr 10, 2018
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC17 citations85
US10899761B2Jan 26, 2021
Heterocyclic compounds and uses thereof
PLEXXIKON INC4 citations84
US10647716B2May 12, 2020
Heterocyclic compounds and uses thereof
PLEXXIKON INC7 citations84
US10501460B2Dec 10, 2019
Heterocyclic compounds and uses thereof
PLEXXIKON INC6 citations84
US10426760B2Oct 1, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC6 citations84
US10301280B2May 28, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC6 citations84
US10227357B2Mar 12, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC7 citations84
US10428067B2Oct 1, 2019
Compounds and methods for kinase modulation
PLEXXIKON INC8 citations83
US10160747B2Dec 25, 2018
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC8 citations83
US10421761B2Sep 24, 2019
Compounds for kinase modulation, and indications therefor
PLEXXIKON INC6 citations82
US10160755B2Dec 25, 2018
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC15 citations81
US11337976B2May 24, 2022
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC1 citations73
US10519177B2Dec 31, 2019
Heterocyclic compounds and uses thereof
PLEXXIKON INC4 citations73
US10703757B2Jul 7, 2020
Compounds and methods for CDK8 modulation and indications therefor
PLEXXIKON INC4 citations71
US10508085B2Dec 17, 2019
Compounds and methods for IDO and TDO modulation, and indications therefor
PLEXXIKON INC6 citations71
US12076322B2Sep 3, 2024
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC0 citations63
IBRAHIM PRABHA N
8 patentsUS8673928B2Mar 18, 2014
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N60 citations98
US8198273B2Jun 12, 2012
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N65 citations98
US8129404B2Mar 6, 2012
Compounds and uses thereof
IBRAHIM PRABHA N50 citations98
US8901301B2Dec 2, 2014
Pyrrolo[2,3-]pyridine kinase inhibitors
IBRAHIM PRABHA N52 citations97
US8470818B2Jun 25, 2013
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N94 citations97
US8415469B2Apr 9, 2013
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N84 citations97
US8153641B2Apr 10, 2012
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N51 citations94
US8110576B2Feb 7, 2012
Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications
IBRAHIM PRABHA N57 citations94
UNIV CALIFORNIA
2 patentsIBRAHIM PRABHA
1 patentZHANG JIAZHONG
1 patentWU GUOXIAN
1 patentShowing the top 50 of 56 patents by PatentIndex Score.